Multiple Myeloma
News for Multiple Myeloma
People speak for multiple myeloma
Q. Most common site of lytic lesion in multiple myeloma is,A.vertebral columnB.pelvisC.clavicleD.femur
Ataur Rahman:
A. more
http://qna.rediff.com/questions-and-answers/most-common-site-of-lytic-lesion-in-multiple-myeloma-isa.ver/21545816/answers/
Q. From which disease Lisa Ray was suffering, has she fully cured now?
Ataur Rahman:
A. Indo-Canadian actress Lisa Ray was diagnosed with multiple myeloma, an incurable form of blood cancer on 23 June 2009, a cancer of the white blood......
more
http://qna.rediff.com/questions-and-answers/from-which-disease-lisa-ray-was-suffering-has-she-fully-cure/21545816/answers/16984827
Q. How turmeric enhances health and beauty...?
Onewoman:
A. 1. It is a natural antiseptic and antibacterial agent, useful in disinfecting cuts and burns.2. When combined with cauliflower, it has shown to......
more
http://qna.rediff.com/questions-and-answers/how-turmeric-enhances-health-and-beauty.../16984680/answers/16509309
Q. Need reference regarding myeloma (multiple myeloma) specialists in and around coimbatore, Tamilnadu, India. pls.
Jakir Hussain:
A. You can get consultancy from K.G Hospitals or Kuppusamy hospitals cpoimbatore
more
http://qna.rediff.com/questions-and-answers/need-reference-regarding-myeloma-multiple-myeloma-specialist/16506062/answers/16376913
Q. Studies are ongoing in the positive effects of turmeric on multiple myeloma.Your View Please
Marudhavanan :
A. let us wait for results
more
http://qna.rediff.com/questions-and-answers/studies-are-ongoing-in-the-positive-effects-of-turmeric-on-m/16376892/answers/16002267
Web results for Multiple Myeloma
Medivo Raises $15 Million to Further Expand Analytics PlatformSeries B financing led by Merck Global Health Innovation Fund (GHIF) with participation from Safeguard Scientifics (NYSE:SFE) and MentorTech... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=5147&title=Medivo-Raises-$15-Million-to-Further-Expand-Analytics-Platform
Amgen Xgeva Label Expanded - Analyst BlogAmgen (AMGN) recently received approval from the US Food and Drug Administration (FDA) for an additional indication for Xgeva (denosumab). The FDA... ...
http://in.quote.com/news/zacksCache.aspx?id=721821
Data on BMY/ AbbVie's elotuzumab - Analyst BlogBristol-Myers Squibb Company (BMY) and partner AbbVie Inc. (ABBV) recently presented data on their oncology candidate, elotuzumab, from a phase II... ...
http://in.quote.com/news/zacksCache.aspx?id=721599